Superworth

Royalty Pharma market cap RPRX

Share price times shares outstanding: what the whole company sells for, since 2020.

Today, Nov 3, 2026
$38.7B
Highest close in our data
$38.6B
Oct 2026

Royalty Pharma is worth $38.7B at the close on Nov 3, 2026, at $67.30 a share.

That is up 74% over the last year and up 61% over five years.

Its highest close in our data was $38.6B in Oct 2026.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$38.2B$22.4B$38.6B+69%
2025$22.6B$15.2B$23.1B+50%
2024$15B$14.6B$18.5B−10%
2023$16.8B$15.8B$23.9B−30%
2022$24B$23.2B$26.8B−1%
2021$24.2B$18.2B$28.5B+25%
2020$19.4B$13.4B$19.4Bn/a

Against its peers

Companies in Healthcare nearest Royalty Pharma's size, closest first, today.

CompanyMarket cap
RPRXRoyalty Pharma$38.7B
BIIBBiogen$37B
GEHCGE HealthCare Technologies$36B
ONCBeOne Medicines$40.2B
IQVIQVIA$42.5B
ZTSZoetis$34.3B
ILMNIllumina$35.7B
MTDMettler-Toledo International$34.2B
RMDResMed$32.3B
WATWaters$46.4B
MDLNMedline$43.8B
Peer median$36.5B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Royalty Pharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.